News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
704,957 Results
Type
Article (41050)
Company Profile (241)
Press Release (663656)
Multimedia
Podcasts (88)
Webinars (16)
Section
Business (225183)
Career Advice (1173)
Deals (35112)
Drug Delivery (118)
Drug Development (80997)
Employer Resources (94)
FDA (16012)
Job Trends (13924)
News (333725)
Policy (29513)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (4)
2027 Biotech Beach Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (5)
2027 Pharm Country Elite (1)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (5)
Academia (2368)
Academic (1)
Accelerated approval (56)
ADA (39)
Adcomms (33)
Allergies (181)
Alliances (49721)
ALS (230)
Alzheimer's disease (1840)
Antibody-drug conjugate (ADC) (604)
Approvals (16652)
Artificial intelligence (727)
ASCO (329)
Autoimmune disease (379)
Automation (58)
Bankruptcy (347)
Best Places to Work (10791)
BIO (61)
Biologics (1)
BIOSECURE Act (18)
Biosimilars (227)
BioSpace Insights (95)
Biotechnology (168)
Bladder cancer (218)
Brain cancer (76)
Breast cancer (836)
Cancer (6658)
Cardiovascular disease (478)
Career advice (1015)
Career pathing (36)
CAR-T (400)
CDC (42)
Celiac Disease (2)
Cell therapy (1105)
Cervical cancer (54)
Clinical research (71056)
Collaboration (2303)
Commercialization (5)
Company closure (5)
Compensation (1576)
Complete response letters (84)
COVID-19 (2498)
CRISPR (130)
C-suite (1240)
Cystic fibrosis (160)
Data (8817)
Decentralized trials (2)
Denatured (16)
Depression (180)
Dermatology (104)
Diabetes (615)
Diagnostics (6921)
Digital health (63)
Diversity (6)
Diversity, equity & inclusion (30)
Drug discovery (377)
Drug pricing (120)
Drug shortages (15)
Duchenne muscular dystrophy (308)
Earnings (88463)
Editorial (42)
Employer branding (13)
Employer resources (94)
Events (115306)
Executive appointments (1102)
FDA (20182)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (24)
Frontotemporal dementia (34)
Funding (1814)
Gene editing (277)
Generative AI (60)
Gene therapy (811)
GLP-1 (942)
Government (3534)
Grass and pollen (7)
Guidances (420)
Healthcare (17037)
Hematology (191)
HIV (92)
Huntington's disease (65)
IgA nephropathy (112)
Immunology and inflammation (277)
Immuno-oncology (121)
Indications (233)
Infectious disease (2831)
Inflammatory bowel disease (229)
Inflation Reduction Act (10)
Influenza (138)
Intellectual property (331)
Interviews (221)
IPO (16325)
IRA (23)
Job creations (3497)
Job search strategy (836)
JPM (46)
Kidney cancer (26)
Labor market (85)
Layoffs (516)
Leadership (31)
Legal (7223)
Licensing (8)
Liver cancer (108)
Longevity (33)
Lung cancer (920)
Lymphoma (501)
Machine learning (63)
Management (34)
Manufacturing (1123)
Marketing (12)
MASH (197)
Medical affairs (1)
Medical device (13095)
Medtech (13300)
Mergers & acquisitions (20171)
Metabolic disorders (1472)
mRNA (243)
Multiple sclerosis (204)
NASH (20)
Neurodegenerative disease (452)
Neuropsychiatric disorders (94)
Neuroscience (3456)
Neurotech (1)
NextGen: Class of 2026 (5944)
Non-profit (3210)
Now hiring (41)
Obesity (606)
Opinion (218)
Ovarian cancer (251)
Pain (264)
Pancreatic cancer (354)
Parkinson's disease (394)
Partnered (30)
Patents (662)
Patient recruitment (830)
Peanut (56)
People (56601)
Pharmaceutical (47)
Pharmacy benefit managers (18)
Phase 1 (22610)
Phase 2 (31374)
Phase 3 (23031)
Pipeline (10569)
Policy (207)
Postmarket research (2372)
Preclinical (9868)
Press Release (70)
Prostate cancer (347)
Psychedelics (69)
Radiopharmaceuticals (342)
Rare diseases (1167)
Real estate (5423)
Recruiting (39)
Regulatory (24585)
Reports (39)
Research institute (2243)
Resumes & cover letters (171)
Rett syndrome (49)
RNA editing (26)
RSV (80)
Schizophrenia (167)
Series A (315)
Series B (229)
Service/supplier (5)
Sickle cell disease (136)
Special edition (24)
Spinal muscular atrophy (159)
Sponsored (40)
Startups (3645)
State (1)
Stomach cancer (20)
Supply chain (110)
Tariffs (52)
The Weekly (70)
Vaccines (1055)
Venture capital (103)
Weight loss (366)
Women's health (127)
Worklife (14)
Date
Last 7 days (700)
Last 30 days (2121)
Last 365 days (29297)
2026 (18182)
2025 (29255)
2024 (34166)
2023 (39064)
2022 (49888)
2021 (53576)
2020 (50814)
2019 (42013)
2018 (31611)
2017 (30447)
2016 (29520)
2015 (35723)
2014 (29919)
2013 (25786)
2012 (27664)
2011 (27809)
2010 (26479)
Location
Africa (610)
Alabama (100)
Alaska (6)
Arizona (373)
Arkansas (15)
Asia (38885)
Australia (6391)
California (14407)
Canada (4012)
China (1549)
Colorado (596)
Connecticut (590)
Delaware (403)
Europe (83499)
Florida (2147)
Georgia (451)
Hawaii (4)
Idaho (61)
Illinois (1090)
India (101)
Indiana (568)
Iowa (21)
Japan (621)
Kansas (138)
Kentucky (52)
Louisiana (54)
Maine (92)
Maryland (1605)
Massachusetts (10392)
Michigan (353)
Minnesota (754)
Mississippi (5)
Missouri (155)
Montana (30)
Nebraska (23)
Nevada (143)
New Hampshire (83)
New Jersey (3714)
New Mexico (35)
New York (3753)
North Carolina (1723)
North Dakota (11)
Northern California (7328)
Ohio (410)
Oklahoma (23)
Oregon (34)
Pennsylvania (2794)
Puerto Rico (31)
Rhode Island (46)
South America (917)
South Carolina (89)
South Dakota (2)
Southern California (5749)
Tennessee (231)
Texas (2336)
United States (50138)
Utah (416)
Vermont (2)
Virginia (343)
Washington D.C. (59)
Washington State (1139)
West Virginia (4)
Wisconsin (133)
Wyoming (1)
704,957 Results for "cell based delivery inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Toralgen Demonstrates Oral Delivery Across Multiple Diabesity Peptide Classes, Advancing the Potential of Oral Biologics
New preclinical findings demonstrate successful oral delivery of single-, dual- and triple-agonist peptide therapeutics using Toralgen’s proprietary nanoparticle platform, supported by specialized bioanalytical expertise from Veloxity Labs.
August 4, 2026
·
1 min read
Layoffs
Not-so-special delivery: When biopharmas fumble layoff news
So far in 2026, over 50 biopharmas have cut or plan to cut their workforces. If they didn’t take a careful, thoughtful approach to telling people they were being laid off, they likely left a negative impression on employees, based on stories shared with
BioSpace
.
July 30, 2026
·
3 min read
·
Angela Gabriel
Press Releases
Lightship Inc. Acquires Veda Trials to Expand Community-Based Clinical Research Delivery
The acquisition expands scalable trial operations across real-world care settings
February 4, 2026
·
1 min read
Press Releases
Lightship Inc. Acquires Veda Trials to Expand Community-Based Clinical Research Delivery
February 5, 2026
·
3 min read
Press Releases
InSphero AG Acquires PhenoVista Biosciences, Inc. to Expand Advanced 3D, Cell-based Assay Capabilities
May 20, 2026
·
3 min read
Press Releases
Sana Biotechnology Presents Preclinical Data for In Vivo CAR T Cell Therapy SG293 Surrogate Demonstrating Cell-Specific Delivery, Potent CAR T Cell Generation, and Deep B Cell Depletion in NHPs
May 13, 2026
·
8 min read
Press Releases
Cellares and Sonoma Biotherapeutics Collaborate to Automate Manufacturing of SBT-77-7101 Engineered Treg Cell Therapy on the Cell Shuttle® Platform
July 13, 2026
·
5 min read
Press Releases
Vyriad Launches G-Link: A Modular Platform Advancing T-Cell Targeted Lentiviral Vector Delivery for In Vivo and Ex Vivo Applications
May 21, 2026
·
4 min read
Mergers & acquisitions
Lilly adds gene delivery technology to CAR T in up to $7B Kelonia deal
After entering the CAR T space in February, Eli Lilly is “jumping into in vivo CAR-T with both feet” with the acquisition of Kelonia Therapeutics and its gene delivery technology.
April 20, 2026
·
2 min read
·
Annalee Armstrong
Press Releases
Lir Life Sciences Completes Design of a Comparative Animal Study Investigating Cell-Penetrating Peptide-Mediated Delivery of GLP/GIP-Based Obesity Therapies
December 11, 2025
·
5 min read
1 of 70,496
Next
